PSTG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Buy now (tactical). The primary setup is a still-bullish trend (SMA_5 > SMA_20 > SMA_200) with price pulling back toward support (~69.75). Upside is a rebound toward the pivot (72.49) and resistance (75.24) while Wall Street targets remain largely above the current $70.9 despite increased margin/OpEx debate. Options flow is mixed (put-heavy volume), so this is best treated as a near-term technical buy rather than a conviction, long-duration “margin expansion” bet today.
Trend/structure: Bullish moving average stack (SMA_5 > SMA_20 > SMA_200) indicates the primary trend remains up. Momentum: MACD histogram is positive (0.645) but contracting, signaling bullish momentum is fading short-term (common during pullbacks). RSI(6)=52.82 is neutral—no overbought/oversold edge. Levels: Price $70.9 is below the pivot 72.49, suggesting near-term consolidation/pullback, but it is holding above S1=69.75 (key near-term support). If S1 breaks, next support is S2=68.05; upside targets are pivot 72.49 then R1=75.24 (R2=76.94 as extension).
Intellectia Proprietary Trading Signals
while primary trend remains bullish (MA stack).
on 2026-02-25 after hours—potential re-rating catalyst if enterprise acceleration/hyperscaler commentary improves.
suggests near-term hedging or bearish speculation despite call-heavy OI.
Latest quarter: 2026/Q3. Revenue grew to $964.453M (+16.05% YoY), indicating solid top-line demand. Profitability softened: net income fell to $54.806M (-13.88% YoY) and EPS to $0.16 (-15.79% YoY), consistent with higher spending/investment weighing on earnings. Quality signal: gross margin improved to 72.31% (+3.09 YoY), which is a positive offset and supports longer-term operating leverage if OpEx growth moderates.
Recent trend (2025-12-03 cluster): Broadly mixed but still skewed constructive on price targets, with several raises (TD Cowen to $100 Buy, Lake Street to $92 Buy, BofA to $100 Neutral, Barclays to $77 EW, Northland to $77 MP, UBS to $60 Sell). Some caution increased: Morgan Stanley cut to $83 (Equal Weight) and Citi trimmed to $105 (still Buy); Susquehanna downgraded to Neutral (kept $100), citing slower-than-expected hyperscaler scaling clarity. Wall Street pros: (1) Consistent share gains/outperformance vs legacy storage peers, (2) strong revenue growth and high gross margins, (3) meaningful upside to many targets if hyperscaler/enterprise acceleration narrative strengthens. Wall Street cons: (1) OpEx/investment intensity delays margin expansion thesis, (2) uncertainty on hyperscaler scaling timeline/business model, (3) margin/earnings flow-through risk into FY27 and beyond. Notable trades by politicians/influentials: No recent congress trading data available; hedge fund and insider activity shown as Neutral.
